Science & Medicine
A debate has been raging for months around a tiny human cell called the stem cell.
July 23, 2001
Stem cell therapy to be tested on spinal cord injuries
Jan. 24, 2009
The technology’s commercial viability faces many hurdles.
May 10, 2002
Business
Biotech company Geron Corp. said Monday that it had signed a licensing deal with drug maker Merck & Co. to develop a cancer vaccine that targets an enzyme linked to tumor growth, sending Geron shares up 27%.
July 19, 2005
Biotechnology: A new licensing agreement gives the company exclusive rights to three cell types.
Jan. 10, 2002
Geron Corp. on Tuesday won a U.S. patent for technology to develop immune-system-based cancer therapies, news that sent the biotechnology company’s stock up 15%.
Aug. 28, 2002
The stock price of struggling Geron Corp. skyrocketed Tuesday after the company said its experimental cancer vaccine showed promise in fighting all types of the disease.
March 19, 2003
California stem cell agency needs to study itself
Dec. 7, 2011
Economics, not science, thwarts embryonic stem cell therapy
Nov. 21, 2011
Research: Patent holder seeks to stop firm from controlling commercial development.
Aug. 15, 2001